These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
508 related items for PubMed ID: 32789836
1. Spectrum of transthyretin gene mutations and clinical characteristics of Polish patients with cardiac transthyretin amyloidosis. Gawor M, Holcman K, Franaszczyk M, Lipowska M, Michałek P, Teresińska A, Bilińska ZT, Rubiś P, Kostkiewicz M, Szot W, Podolec P, Grzybowski J. Cardiol J; 2022; 29(6):985-993. PubMed ID: 32789836 [Abstract] [Full Text] [Related]
2. Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model. Arvanitis M, Koch CM, Chan GG, Torres-Arancivia C, LaValley MP, Jacobson DR, Berk JL, Connors LH, Ruberg FL. JAMA Cardiol; 2017 Mar 01; 2(3):305-313. PubMed ID: 28196196 [Abstract] [Full Text] [Related]
3. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant. Nehashi T, Oikawa M, Amami K, Kanno Y, Yokokawa T, Misaka T, Yamada S, Kunii H, Nakazato K, Ishida T, Takeishi Y. Int Heart J; 2019 Nov 30; 60(6):1441-1443. PubMed ID: 31666456 [Abstract] [Full Text] [Related]
4. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report. Yamamoto H, Hashimoto T, Kawamura S, Hiroe M, Yamashita T, Ando Y, Yokochi T. J Med Case Rep; 2018 Dec 16; 12(1):370. PubMed ID: 30553273 [Abstract] [Full Text] [Related]
5. Biochemical and biophysical properties of a rare TTRA81V mutation causing mild transthyretin amyloid cardiomyopathy. Sha Q, Zhang Y, Wang M, Sun J, Zhang Y, Zhang X, Wang N, Liu Y, Liu Y. ESC Heart Fail; 2024 Feb 16; 11(1):112-125. PubMed ID: 37827496 [Abstract] [Full Text] [Related]
6. Diagnosis of genetic amyloidosis through the analysis of transthyretin gene mutation using high-resolution melting. Lahuerta C, Menao S, Gracia-Gutierrez A, Bueno-Juana E, Guillén N, Sorribas V, Gracia AA, Aibar MA. Int J Cardiol; 2020 Feb 15; 301():220-225. PubMed ID: 31740141 [Abstract] [Full Text] [Related]
7. First Norwegian case of hereditary ATTR amyloidosis with a novel transthyretin variant. Lyng CS, Gude E, Hodt A, Knudsen EC. Scand Cardiovasc J; 2023 Dec 15; 57(1):2174269. PubMed ID: 36734834 [Abstract] [Full Text] [Related]
8. Diagnostic Pitfall and Clinical Characteristics of Variant Versus Wild-Type Transthyretin Amyloid Cardiomyopathy in Asian Population: The Korean Nationwide Cohort Study. Kim D, Youn JC, Lee HW, Oh J, Son JW, Cho HJ, Lee S, Shah NR, Kittleson MM, Jeon ES. J Korean Med Sci; 2024 May 20; 39(19):e163. PubMed ID: 38769922 [Abstract] [Full Text] [Related]
13. Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy. Porcari A, Razvi Y, Masi A, Patel R, Ioannou A, Rauf MU, Hutt DF, Rowczenio D, Gilbertson J, Martinez-Naharro A, Venneri L, Whelan C, Lachmann H, Wechalekar A, Quarta CC, Merlo M, Sinagra G, Hawkins PN, Fontana M, Gillmore JD. Eur J Heart Fail; 2023 Apr 20; 25(4):515-524. PubMed ID: 36644836 [Abstract] [Full Text] [Related]
14. Amyloid Cardiomyopathy in the Rare Transthyretin Tyr78Phe Mutation. Tini G, Vianello PF, Gemelli C, Grandis M, Canepa M. J Cardiovasc Transl Res; 2019 Dec 20; 12(6):514-516. PubMed ID: 30604309 [Abstract] [Full Text] [Related]
15. Rare variant (p.Ser43Asn) of familial transthyretin amyloidosis associated with isolated cardiac phenotype: A case series with literature review. Papathanasiou M, Carpinteiro A, Kersting D, Jakstaite AM, Hagenacker T, Schlosser TW, Rischpler C, Rassaf T, Luedike P. Mol Genet Genomic Med; 2021 Dec 20; 9(12):e1581. PubMed ID: 33345470 [Abstract] [Full Text] [Related]
16. DISCOVERY: prevalence of transthyretin (TTR) mutations in a US-centric patient population suspected of having cardiac amyloidosis. Akinboboye O, Shah K, Warner AL, Damy T, Taylor HA, Gollob J, Powell C, Karsten V, Vest J, Maurer MS. Amyloid; 2020 Dec 20; 27(4):223-230. PubMed ID: 32456532 [Abstract] [Full Text] [Related]
17. Impact of Genetic Testing in Transthyretin (ATTR) Cardiac Amyloidosis. Gopal DM, Ruberg FL, Siddiqi OK. Curr Heart Fail Rep; 2019 Oct 20; 16(5):180-188. PubMed ID: 31520266 [Abstract] [Full Text] [Related]
18. Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis. Rapezzi C, Quarta CC, Guidalotti PL, Pettinato C, Fanti S, Leone O, Ferlini A, Longhi S, Lorenzini M, Reggiani LB, Gagliardi C, Gallo P, Villani C, Salvi F. JACC Cardiovasc Imaging; 2011 Jun 20; 4(6):659-70. PubMed ID: 21679902 [Abstract] [Full Text] [Related]
19. Magnetic Resonance in Transthyretin Cardiac Amyloidosis. Martinez-Naharro A, Treibel TA, Abdel-Gadir A, Bulluck H, Zumbo G, Knight DS, Kotecha T, Francis R, Hutt DF, Rezk T, Rosmini S, Quarta CC, Whelan CJ, Kellman P, Gillmore JD, Moon JC, Hawkins PN, Fontana M. J Am Coll Cardiol; 2017 Jul 25; 70(4):466-477. PubMed ID: 28728692 [Abstract] [Full Text] [Related]
20. Rare c.302C>T TTR Variant Associated with Transthyretin Amyloidosis. Žebrauskienė D, Sadauskienė E, Masiulienė R, Aidietienė S, Šiaudinienė A, Pečeliūnas V, Žukauskaitė G, Žurauskas E, Valevičienė N, Barysienė J, Preikšaitienė E. Medicina (Kaunas); 2024 Jan 30; 60(2):. PubMed ID: 38399526 [Abstract] [Full Text] [Related] Page: [Next] [New Search]